Jowi Tsidkenu Pili Cruz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jowi Tsidkenu Pili Cruz has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Amelda C. Libres
College of Medical Laboratory Science, Liceo de Cagayan University, Cagayan de Oro City 9000, Philippines
5 shared publications - Christian Joseph Navarro Ong
Manila Central University, Caloocan, Philippines
5 shared publications - Jamil Allen G. Fortaleza
National University, Manila 1008, Philippines
5 shared publications - Joel G. Matamis
School of Medical Laboratory Sciences, St. Dominic College of Asia, Bacoor 4102, Philippines
5 shared publications - Jose Edwardo R. Mamaat
Department of Medical Technology, Far Eastern University, Manila 1008, Philippines
5 shared publications - Jose Jurel M. Nuevo
College of Medical Laboratory Science, Our Lady of Fatima University, Valenzuela City 1440, Philippines
5 shared publications
Latest Publications
- Open Access
- 29 October 2026
- Published by Springer Nature in Beni-Suef University Journal of Basic and Applied Sciences
- Vol. 15 (1) , 118
Quorum sensing research in bioluminescent bacteria: a global scientometric mapping of research trends, knowledge structure and emerging research frontiers
Background: Quorum sensing (QS) in bioluminescent bacteria underpins bacterial cell-to-cell communication, but the global evolution of this field has not been comprehensively evaluated scientometrically. This study maps QS research in bioluminescent bacteria to assess its developmental trajectory, intellectual structure, collaboration networks, and emerging frontiers. Main body: A comprehensive Scopus search yielded 1,470 original articles published between 1977 and 2025. After data cleaning and standardization, Bibliometrix/Biblioshiny and VOSviewer were used to analyse publication trends, citations, leading authors, institutions, journals, countries, co-authorship, keyword co-occurrence, thematic evolution, strategic thematic mapping, and multidimensional scaling. Publication output grew steadily, accelerating after 2006 and peaking in the early 2020s. The United States and China were the leading contributors, while Princeton University, Ghent University, and Bonnie L. Bassler were particularly influential. Research themes shifted from LuxI/LuxR signaling, bacterial luminescence, and autoinduction toward biofilm regulation, quorum quenching, antimicrobial discovery, aquaculture, microbial ecology, omics technologies, and systems biology. Collaboration became increasingly international and multidisciplinary. Conclusion: This study provides the first comprehensive scientometric synthesis of QS research in bioluminescent bacteria, identifying key contributors, evolving knowledge structures, translational gaps, and emerging priorities for future research in microbial communication, biotechnology, environmental microbiology, and anti-virulence research.
- 29 October 2026
- Published by Springer Nature in Beni-Suef University Journal of Basic and Applied Sciences
- Vol. 15 (1) , 118
Open AccessQuorum sensing research in bioluminescent bacteria: a global scientometric mapping of research trends, knowledge structure and emerging research frontiers
Background: Quorum sensing (QS) in bioluminescent bacteria underpins bacterial cell-to-cell communication, but the global evolution of this field has not been comprehensively evaluated scientometrically. This study maps QS research in bioluminescent bacteria to assess its developmental trajectory, intellectual structure, collaboration networks, and emerging frontiers. Main body: A comprehensive Scopus search yielded 1,470 original articles published between 1977 and 2025. After data cleaning and standardization, Bibliometrix/Biblioshiny and VOSviewer were used to analyse publication trends, citations, leading authors, institutions, journals, countries, co-authorship, keyword co-occurrence, thematic evolution, strategic thematic mapping, and multidimensional scaling. Publication output grew steadily, accelerating after 2006 and peaking in the early 2020s. The United States and China were the leading contributors, while Princeton University, Ghent University, and Bonnie L. Bassler were particularly influential. Research themes shifted from LuxI/LuxR signaling, bacterial luminescence, and autoinduction toward biofilm regulation, quorum quenching, antimicrobial discovery, aquaculture, microbial ecology, omics technologies, and systems biology. Collaboration became increasingly international and multidisciplinary. Conclusion: This study provides the first comprehensive scientometric synthesis of QS research in bioluminescent bacteria, identifying key contributors, evolving knowledge structures, translational gaps, and emerging priorities for future research in microbial communication, biotechnology, environmental microbiology, and anti-virulence research.
- Open Access
- 27 October 2026
- Published by MDPI AG in Environments
- Vol. 13 (11) , 583
Economic Valuation and Impact Assessment of Biodiversity and Ecosystem Services: A Scientometric and Narrative Review
Biodiversity loss and ecosystem degradation highlight the need to better integrate ecosystem service value into environmental decision-making. This study examined global research on the economic valuation and impact assessment of biodiversity and ecosystem services through scientometric analysis and narrative synthesis. A total of 2131 Scopus-indexed articles published from 1975 to 2025 were analyzed using Bibliometrix/Biblioshiny version 5.0 and VOSviewer version 1.6.20. Research output increased substantially after 2008, reflecting growing scientific and policy interest in biodiversity valuation and ecosystem services. The United States, the United Kingdom, and China dominated the literature, while several biodiversity-rich regions remained underrepresented. Major research themes included ecosystem services, biodiversity conservation, economic valuation, sustainability, willingness to pay, and environmental policy, with emerging attention to natural capital, ecological restoration, and decision support. The narrative synthesis identified persistent challenges, including methodological differences, limited valuation of cultural and non-market services, insufficient baseline data, and inconsistent integration of valuation into environmental impact assessment. Overall, the findings emphasize the need for more inclusive, context-sensitive, and integrated valuation approaches to strengthen environmental assessment and support evidence-based conservation and policy decisions.
- 27 October 2026
- Published by MDPI AG in Environments
- Vol. 13 (11) , 583
Open AccessEconomic Valuation and Impact Assessment of Biodiversity and Ecosystem Services: A Scientometric and Narrative Review
Biodiversity loss and ecosystem degradation highlight the need to better integrate ecosystem service value into environmental decision-making. This study examined global research on the economic valuation and impact assessment of biodiversity and ecosystem services through scientometric analysis and narrative synthesis. A total of 2131 Scopus-indexed articles published from 1975 to 2025 were analyzed using Bibliometrix/Biblioshiny version 5.0 and VOSviewer version 1.6.20. Research output increased substantially after 2008, reflecting growing scientific and policy interest in biodiversity valuation and ecosystem services. The United States, the United Kingdom, and China dominated the literature, while several biodiversity-rich regions remained underrepresented. Major research themes included ecosystem services, biodiversity conservation, economic valuation, sustainability, willingness to pay, and environmental policy, with emerging attention to natural capital, ecological restoration, and decision support. The narrative synthesis identified persistent challenges, including methodological differences, limited valuation of cultural and non-market services, insufficient baseline data, and inconsistent integration of valuation into environmental impact assessment. Overall, the findings emphasize the need for more inclusive, context-sensitive, and integrated valuation approaches to strengthen environmental assessment and support evidence-based conservation and policy decisions.
- Open Access
- 5 October 2026
- Published by Springer Nature in Discover Artificial Intelligence
- Vol. 6 (1) , 1354
Artificial intelligence approaches to resistome profiling and predictive antimicrobial resistance surveillance
Antimicrobial resistance (AMR) is a complex One Health challenge driven by the interconnected emergence, selection, persistence, and dissemination of resistance across clinical, animal, agricultural, food, and environmental microbiomes. Resistome profiling through whole-genome and metagenomic sequencing has transformed surveillance by enabling comprehensive characterization of antimicrobial resistance genes (ARGs); however, conventional homology-based approaches remain constrained by incomplete reference databases and may overlook divergent or previously uncharacterized resistance determinants. This review critically examines how artificial intelligence (AI), including machine learning, deep learning, transformer architectures, and biological language models, is advancing resistome profiling through ARG detection and classification, prioritization of putative novel resistance determinants, antimicrobial resistance phenotype prediction, and inference of microbial host and mobile genetic element associations. Particular emphasis is placed on the conceptual distinction between detecting resistance-associated sequence features and forecasting the future emergence of AMR. Although AI can identify sequence patterns associated with resistance and integrate genomic, metagenomic, multi-omic, clinical, epidemiological, and environmental data to estimate risk, these predictions do not independently establish that a candidate determinant will confer resistance in a new host, undergo successful horizontal transfer, persist within microbial populations, or become selectively advantageous under future ecological or clinical conditions. Resistance emergence is contingent on gene expression, genomic background, host compatibility, mobility, fitness effects, selection pressure, ecological persistence, and epidemiological connectivity. Accordingly, current AI outputs should generally be interpreted as detection, prioritization, phenotype prediction, or risk estimation rather than definitive forecasts of future resistance emergence. Major translational barriers include database bias, phylogenetic confounding, model opacity, limited genotype–phenotype data, poor external generalizability, inconsistent metadata, and insufficient prospective and experimental validation. Future progress will require biologically interpretable models, harmonized longitudinal One Health datasets, explicit evidence grading, and prospective validation against predefined emergence outcomes to establish whether AI-derived early-warning signals provide reliable and actionable lead time for AMR surveillance.
- 5 October 2026
- Published by Springer Nature in Discover Artificial Intelligence
- Vol. 6 (1) , 1354
Open AccessArtificial intelligence approaches to resistome profiling and predictive antimicrobial resistance surveillance
Antimicrobial resistance (AMR) is a complex One Health challenge driven by the interconnected emergence, selection, persistence, and dissemination of resistance across clinical, animal, agricultural, food, and environmental microbiomes. Resistome profiling through whole-genome and metagenomic sequencing has transformed surveillance by enabling comprehensive characterization of antimicrobial resistance genes (ARGs); however, conventional homology-based approaches remain constrained by incomplete reference databases and may overlook divergent or previously uncharacterized resistance determinants. This review critically examines how artificial intelligence (AI), including machine learning, deep learning, transformer architectures, and biological language models, is advancing resistome profiling through ARG detection and classification, prioritization of putative novel resistance determinants, antimicrobial resistance phenotype prediction, and inference of microbial host and mobile genetic element associations. Particular emphasis is placed on the conceptual distinction between detecting resistance-associated sequence features and forecasting the future emergence of AMR. Although AI can identify sequence patterns associated with resistance and integrate genomic, metagenomic, multi-omic, clinical, epidemiological, and environmental data to estimate risk, these predictions do not independently establish that a candidate determinant will confer resistance in a new host, undergo successful horizontal transfer, persist within microbial populations, or become selectively advantageous under future ecological or clinical conditions. Resistance emergence is contingent on gene expression, genomic background, host compatibility, mobility, fitness effects, selection pressure, ecological persistence, and epidemiological connectivity. Accordingly, current AI outputs should generally be interpreted as detection, prioritization, phenotype prediction, or risk estimation rather than definitive forecasts of future resistance emergence. Major translational barriers include database bias, phylogenetic confounding, model opacity, limited genotype–phenotype data, poor external generalizability, inconsistent metadata, and insufficient prospective and experimental validation. Future progress will require biologically interpretable models, harmonized longitudinal One Health datasets, explicit evidence grading, and prospective validation against predefined emergence outcomes to establish whether AI-derived early-warning signals provide reliable and actionable lead time for AMR surveillance.
- Open Access
Mapping Bacteriophage-Based Antimicrobial Research in Southeast Asia: A Bibliometric Analysis of Scientific Productivity, Knowledge Structure, and Emerging Research Pathways
Southeast Asia faces a substantial burden of antimicrobial resistance (AMR), creating increasing interest in bacteriophage-based antimicrobial strategies. However, the regional development, contributors, collaboration patterns, and evolving research priorities of this field remain insufficiently characterized. This study conducted a bibliometric analysis of Scopus-indexed publications on bacteriophage-based antimicrobial research affiliated with Southeast Asian countries from 1981 to 2025. Bibliometrix/Biblioshiny and VOSviewer were used to evaluate scientific production, citation patterns, leading contributors, collaboration networks, and conceptual and thematic development. A total of 862 publications were analyzed, with scientific output accelerating markedly after 2019 and reaching its highest level in 2025. Thailand emerged as the dominant regional contributor, with Vongkamjan (n = 21) and Surachat (n = 20) as the two most prolific authors. Mahidol University (n = 182), Prince of Songkla University (n = 142), and Universiti Putra Malaysia (n = 139) were the leading institutions, demonstrating a concentration of research capacity in Thailand and Malaysia. Scientific Reports was the most productive journal (30 publications), whereas Frontiers in Microbiology recorded the highest citation count among the leading sources (963 citations). Collaboration mapping revealed increasingly interconnected regional and international research networks. Thematic analyses demonstrated a transition from foundational and pathogen-specific investigations toward AMR, bacteriophage therapy, biofilm control, aquaculture, genomic and comparative genomic analysis, wastewater and public-health applications, and One Health-oriented research. Emerging topics included endolysins, quorum sensing, CRISPR-associated approaches, metagenomics, and genome-informed phage characterization. These findings demonstrate the rapid expansion and thematic diversification of bacteriophage-based antimicrobial research in Southeast Asia while highlighting persistent geographic concentration and the need for stronger regional infrastructure, collaboration, and translational capacity.
Open AccessMapping Bacteriophage-Based Antimicrobial Research in Southeast Asia: A Bibliometric Analysis of Scientific Productivity, Knowledge Structure, and Emerging Research Pathways
Southeast Asia faces a substantial burden of antimicrobial resistance (AMR), creating increasing interest in bacteriophage-based antimicrobial strategies. However, the regional development, contributors, collaboration patterns, and evolving research priorities of this field remain insufficiently characterized. This study conducted a bibliometric analysis of Scopus-indexed publications on bacteriophage-based antimicrobial research affiliated with Southeast Asian countries from 1981 to 2025. Bibliometrix/Biblioshiny and VOSviewer were used to evaluate scientific production, citation patterns, leading contributors, collaboration networks, and conceptual and thematic development. A total of 862 publications were analyzed, with scientific output accelerating markedly after 2019 and reaching its highest level in 2025. Thailand emerged as the dominant regional contributor, with Vongkamjan (n = 21) and Surachat (n = 20) as the two most prolific authors. Mahidol University (n = 182), Prince of Songkla University (n = 142), and Universiti Putra Malaysia (n = 139) were the leading institutions, demonstrating a concentration of research capacity in Thailand and Malaysia. Scientific Reports was the most productive journal (30 publications), whereas Frontiers in Microbiology recorded the highest citation count among the leading sources (963 citations). Collaboration mapping revealed increasingly interconnected regional and international research networks. Thematic analyses demonstrated a transition from foundational and pathogen-specific investigations toward AMR, bacteriophage therapy, biofilm control, aquaculture, genomic and comparative genomic analysis, wastewater and public-health applications, and One Health-oriented research. Emerging topics included endolysins, quorum sensing, CRISPR-associated approaches, metagenomics, and genome-informed phage characterization. These findings demonstrate the rapid expansion and thematic diversification of bacteriophage-based antimicrobial research in Southeast Asia while highlighting persistent geographic concentration and the need for stronger regional infrastructure, collaboration, and translational capacity.
- Open Access
Bioactivity Research in Ganoderma lucidum: A Scientometric Analysis of Global Trends, Translational Gaps, and Emerging Research Frontiers
Ganoderma lucidum (Lingzhi or Reishi) is among the most extensively studied medicinal mushrooms globally, owing to its diverse bioactive compounds and broad pharmacological properties. A scientometric analysis using the Scopus database was conducted to investigate global research trends on the bioactivity of G. lucidum. Bibliometric indicators, collaboration networks, keyword co-occurrence, thematic evolution, conceptual structure mapping, and life cycle modeling were assessed using Bibliometrix/Biblioshiny and VOSviewer version 1.6.20. A total of 2877 publications were included in the analysis. Scientific output increased markedly after 2010, peaking in 2025, indicating sustained growth in the field. China was identified as the leading contributor in terms of publication volume, influential authors, and prominent institutions, while international collaboration networks showed expanding global participation. Keyword and thematic analyses demonstrated a shift from early research focused on bioactivity screening, polysaccharides, and cultivation to mechanistic and translational investigations involving apoptosis, oxidative stress, immunomodulation, metabolomics, gut microbiota, network pharmacology, and disease-specific applications. Life cycle analysis suggested that the field is still in a rapid growth phase and has not yet reached saturation. Research on G. lucidum has evolved into a mature and highly interdisciplinary field, characterized by increasing scientific productivity, expanding international collaboration, and a growing emphasis on mechanistic and translational studies.
Open AccessBioactivity Research in Ganoderma lucidum: A Scientometric Analysis of Global Trends, Translational Gaps, and Emerging Research Frontiers
Ganoderma lucidum (Lingzhi or Reishi) is among the most extensively studied medicinal mushrooms globally, owing to its diverse bioactive compounds and broad pharmacological properties. A scientometric analysis using the Scopus database was conducted to investigate global research trends on the bioactivity of G. lucidum. Bibliometric indicators, collaboration networks, keyword co-occurrence, thematic evolution, conceptual structure mapping, and life cycle modeling were assessed using Bibliometrix/Biblioshiny and VOSviewer version 1.6.20. A total of 2877 publications were included in the analysis. Scientific output increased markedly after 2010, peaking in 2025, indicating sustained growth in the field. China was identified as the leading contributor in terms of publication volume, influential authors, and prominent institutions, while international collaboration networks showed expanding global participation. Keyword and thematic analyses demonstrated a shift from early research focused on bioactivity screening, polysaccharides, and cultivation to mechanistic and translational investigations involving apoptosis, oxidative stress, immunomodulation, metabolomics, gut microbiota, network pharmacology, and disease-specific applications. Life cycle analysis suggested that the field is still in a rapid growth phase and has not yet reached saturation. Research on G. lucidum has evolved into a mature and highly interdisciplinary field, characterized by increasing scientific productivity, expanding international collaboration, and a growing emphasis on mechanistic and translational studies.
- Open Access
- 25 June 2026
- Published by MDPI AG in Antibiotics
- Vol. 15 (7) , 635
Artificial Intelligence in Bacteriophage Science: A Comprehensive Narrative Review of Applications, Challenges, and Translational Opportunities
Antimicrobial resistance and persistent biofilm-associated infections have renewed interest in bacteriophages as alternatives or complements to conventional antibiotics. However, broader therapeutic adoption remains constrained by slow phage discovery, incomplete genome characterization, narrow host range, complex therapeutic matching, and manufacturing variability. Artificial intelligence (AI) offers computational approaches that may help address several of these limitations. This comprehensive narrative review discusses current AI applications across the bacteriophage pipeline, including metagenomic phage discovery, genome annotation, phage–host interaction prediction, personalized phage selection, cocktail optimization, and phage–antibiotic combination design. The review also examines AI-assisted synthetic biology approaches, including receptor-binding protein redesign, CRISPR-enabled engineering, generative genome design, and biosafety screening, as well as emerging applications in bioprocess optimization, yield prediction, purification analytics, quality assurance, and supply-chain management. Current evidence suggests that AI may accelerate phage identification, improve host-range prediction, support therapeutic optimization, and strengthen manufacturing consistency, potentially facilitating the transition of phage therapy from individualized rescue interventions toward more scalable antimicrobial platforms. Nevertheless, major limitations remain, including fragmented, taxonomically biased datasets; limited external validation; restricted interpretability; privacy concerns; biosafety oversight; and evolving regulatory frameworks. Future progress will depend on standardized datasets, multimodal validation, scalable manufacturing systems, experimental and clinical verification, and coordinated regulatory development.
- 25 June 2026
- Published by MDPI AG in Antibiotics
- Vol. 15 (7) , 635
Open AccessArtificial Intelligence in Bacteriophage Science: A Comprehensive Narrative Review of Applications, Challenges, and Translational Opportunities
Antimicrobial resistance and persistent biofilm-associated infections have renewed interest in bacteriophages as alternatives or complements to conventional antibiotics. However, broader therapeutic adoption remains constrained by slow phage discovery, incomplete genome characterization, narrow host range, complex therapeutic matching, and manufacturing variability. Artificial intelligence (AI) offers computational approaches that may help address several of these limitations. This comprehensive narrative review discusses current AI applications across the bacteriophage pipeline, including metagenomic phage discovery, genome annotation, phage–host interaction prediction, personalized phage selection, cocktail optimization, and phage–antibiotic combination design. The review also examines AI-assisted synthetic biology approaches, including receptor-binding protein redesign, CRISPR-enabled engineering, generative genome design, and biosafety screening, as well as emerging applications in bioprocess optimization, yield prediction, purification analytics, quality assurance, and supply-chain management. Current evidence suggests that AI may accelerate phage identification, improve host-range prediction, support therapeutic optimization, and strengthen manufacturing consistency, potentially facilitating the transition of phage therapy from individualized rescue interventions toward more scalable antimicrobial platforms. Nevertheless, major limitations remain, including fragmented, taxonomically biased datasets; limited external validation; restricted interpretability; privacy concerns; biosafety oversight; and evolving regulatory frameworks. Future progress will depend on standardized datasets, multimodal validation, scalable manufacturing systems, experimental and clinical verification, and coordinated regulatory development.
- Open Access
Global Research Landscape and Thematic Evolution of Fungi-Derived Antimicrobials Against Methicillin-Resistant Staphylococcus aureus (MRSA): A Scientometric Analysis
Methicillin-resistant Staphylococcus aureus (MRSA) remains a significant multidrug-resistant pathogen, frequently associated with persistent infections and biofilm formation, underscoring the urgent need for alternative antimicrobial strategies. Bioactive compounds derived from fungi have attracted considerable attention due to their structural diversity and demonstrated antibacterial activity against MRSA. This study employed a scientometric approach to assess global research trends, thematic evolution, and collaborative networks concerning fungi-derived anti-MRSA compounds. Bibliographic data were collected from the Scopus database, and a total of 1666 English-language articles and reviews published up to 2025 were analyzed using Bibliometrix/Biblioshiny and VOSviewer. The findings indicate a marked increase in research output after 2010, reflecting heightened scientific interest in fungal natural products for MRSA management. China and the United States emerged as leading contributors in terms of publication volume and international collaboration. Thematic analysis revealed a shift from broad antimicrobial screening to more specialized investigations, including antibiofilm activity, secondary metabolites, endophytic fungi, molecular docking, and antimicrobial resistance. Nonetheless, several challenges persist, such as insufficient mechanistic validation, limited toxicity and pharmacokinetic assessments, and a lack of clinically relevant in vivo studies. Overall, the field is increasingly multidisciplinary, integrating microbiology, natural product chemistry, and computational methodologies to advance the discovery of anti-MRSA agents.
Open AccessGlobal Research Landscape and Thematic Evolution of Fungi-Derived Antimicrobials Against Methicillin-Resistant Staphylococcus aureus (MRSA): A Scientometric Analysis
Methicillin-resistant Staphylococcus aureus (MRSA) remains a significant multidrug-resistant pathogen, frequently associated with persistent infections and biofilm formation, underscoring the urgent need for alternative antimicrobial strategies. Bioactive compounds derived from fungi have attracted considerable attention due to their structural diversity and demonstrated antibacterial activity against MRSA. This study employed a scientometric approach to assess global research trends, thematic evolution, and collaborative networks concerning fungi-derived anti-MRSA compounds. Bibliographic data were collected from the Scopus database, and a total of 1666 English-language articles and reviews published up to 2025 were analyzed using Bibliometrix/Biblioshiny and VOSviewer. The findings indicate a marked increase in research output after 2010, reflecting heightened scientific interest in fungal natural products for MRSA management. China and the United States emerged as leading contributors in terms of publication volume and international collaboration. Thematic analysis revealed a shift from broad antimicrobial screening to more specialized investigations, including antibiofilm activity, secondary metabolites, endophytic fungi, molecular docking, and antimicrobial resistance. Nonetheless, several challenges persist, such as insufficient mechanistic validation, limited toxicity and pharmacokinetic assessments, and a lack of clinically relevant in vivo studies. Overall, the field is increasingly multidisciplinary, integrating microbiology, natural product chemistry, and computational methodologies to advance the discovery of anti-MRSA agents.
- Open Access
Fetomaternal outcomes among cesarean section parturients administered with norepinephrine vs. phenylephrine for post-spinal anesthesia hypotension: A systematic review and meta-analysis
Post-spinal anesthesia hypotension during cesarean delivery poses significant risks to maternal cardiac output and fetal oxygenation. Although phenylephrine (PE) is the standard vasopressor, its use is linked to an increased incidence of maternal bradycardia. In contrast, norepinephrine (NE) offers a more favorable hemodynamic profile and is emerging as a promising alternative. This systematic review and meta-analysis of 18 randomized controlled trials compared NE and PE for the prevention and treatment of post-spinal hypotension in cesarean section parturients. Our findings demonstrate that while NE and PE are equally effective in managing hypotension, NE significantly reduces the incidence of maternal bradycardia (OR = 0.49 [CI: 0.38 to 0.62]) and shows a trend toward fewer adverse maternal events, such as dizziness and reactive hypertension. Additionally, neonatal outcomes indicated a lower birth weight with NE—although still within the normal range—along with tendencies toward lower umbilical arterial lactate levels and improved umbilical vein blood gas pH. These results support NE as a viable alternative to PE, particularly for lowering the incidence of maternal bradycardia, and provide crucial evidence for updating clinical practice guidelines to enhance maternal and neonatal care during cesarean deliveries. Systematic review registration ID: CRD42024593459 https://www.crd.york.ac.uk/PROSPERO/view/CRD42024593459
Open AccessFetomaternal outcomes among cesarean section parturients administered with norepinephrine vs. phenylephrine for post-spinal anesthesia hypotension: A systematic review and meta-analysis
Post-spinal anesthesia hypotension during cesarean delivery poses significant risks to maternal cardiac output and fetal oxygenation. Although phenylephrine (PE) is the standard vasopressor, its use is linked to an increased incidence of maternal bradycardia. In contrast, norepinephrine (NE) offers a more favorable hemodynamic profile and is emerging as a promising alternative. This systematic review and meta-analysis of 18 randomized controlled trials compared NE and PE for the prevention and treatment of post-spinal hypotension in cesarean section parturients. Our findings demonstrate that while NE and PE are equally effective in managing hypotension, NE significantly reduces the incidence of maternal bradycardia (OR = 0.49 [CI: 0.38 to 0.62]) and shows a trend toward fewer adverse maternal events, such as dizziness and reactive hypertension. Additionally, neonatal outcomes indicated a lower birth weight with NE—although still within the normal range—along with tendencies toward lower umbilical arterial lactate levels and improved umbilical vein blood gas pH. These results support NE as a viable alternative to PE, particularly for lowering the incidence of maternal bradycardia, and provide crucial evidence for updating clinical practice guidelines to enhance maternal and neonatal care during cesarean deliveries. Systematic review registration ID: CRD42024593459 https://www.crd.york.ac.uk/PROSPERO/view/CRD42024593459